Method Profile

BET-Inhibitor Response in NPC1 Patient-Derived Cortical Neurons

Patient-derived cortical neurons support separate measurements of cholesterol accumulation, apoptotic staining and NPC1 protein response to JQ1.

Brain & Neural ModelsHuman Cell Assays
Transparent 6-, 24- and 96-well cell-culture plates on a white surface.
Multiwell cell-culture plates. (Lilly_M, CC BY-SA 3.0)

Research Applications

Mechanistic comparison of candidate interventions in an NPC1-associated human neuronal phenotype.

Model & Design

iPSC-derived cortical neurons from one patient homozygous for NPC1 I1061T, compared with healthy-control neurons.

Experimental Format

Day-30 neurons exposed to JQ1 at 0.3, 1 or 3 μM for up to 72 hours, with untreated and vehicle controls.

Model Components

  • Component

    Cell systems

    Description

    Patient and control cortical neurons expressing TUJ1/TBR1.

  • Component

    Measurements

    Description

    Filipin fluorescence, TUNEL-positive cell proportion, NPC1 immunoblotting and morphological inspection.

Measurements & Endpoints

  • Unesterified-cholesterol staining
  • TUNEL-positive cell proportion
  • NPC1 protein abundance
  • Neuronal morphology

Analysis

Analyze each endpoint against its matched control and preserve the distinct concentration and time comparisons.

Published Evidence

  • Study Design

    Compare patient and control baseline phenotypes, then assess JQ1 concentration and time responses.

    Study Sample

    One patient genetic background; selected imaging/protein assays report n = 3 repeats, not three donors.

    Comparison

    Healthy-control neurons, untreated cultures and DMSO vehicle conditions.

    Finding

    JQ1 reduced filipin and TUNEL-associated measurements and increased NPC1 protein, with the largest responses generally at 72 hours.

    Interpretation & Limits
    • The relationship between BET inhibition, NPC1 abundance and cholesterol handling remains mechanistically unresolved.
    • A single patient variant/background and short exposure limit population and long-term inference.
    • The source is a preprint.

Sources

  1. Pharmacological BET Protein Inhibition Reverts Niemann-Pick Type C Disease-Associated Changes in Human iPSC-Derived Cortical Neurons. bioRxiv. 2026. DOI: 10.64898/2026.08.31.747771 ↗